The Amyotrophic Lateral Sclerosis House Call Program: A Single‐Center Experience in the United States
Neurology Research International · 2026-01 · 2026 (1)
DOI: 10.1155/nri/6629960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Research International, online erschienen am 27.02.2026. Verfasst von Erica Scirocco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Massachusetts General Hospital, Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Boston,…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Accessing multidisciplinary care poses challenges for people living with amyotrophic lateral sclerosis (ALS) due to mobility issues. As ALS care rarely requires hospital‐based technology, most care is available through home visits. The Daniella Lipper ALS House Call Program (HCP) at Massachusetts General Hospital (MGH), launched in 2017 in collaboration with Compassionate Care ALS, has pioneered home‐based ALS care in Eastern Massachusetts.
Methods
A retrospective chart review of ALS and primary lateral sclerosis (PLS) patients enrolled in the HCP at MGH was conducted. Data on demographics, visit details, and procedures performed during home visits were collected from electronic health records for patients seen from January 2024 to December 2024.
Results
In 2024, the ALS HCP conducted 959 visits for 142 patients (average age: 68 years, range: 36–93; 47.9% female). Of these patients, 137 (96.5%) were diagnosed with ALS and 5 (3.5%) with PLS. Notably, 61 patients (43%) received care exclusively at home. Key interventions included 44 gastrostomy tube exchanges and 59 respiratory assessments, both of which significantly reduced hospital visits. The average distance traveled by the care team was 30.32 miles per visit.
Conclusions
The Daniella Lipper ALS HCP at MGH brings ALS expertise into the patient’s home, minimizing travel burdens and ensuring continuity of care. The program illustrates the feasibility and impact of home‐based ALS care, suggesting potential for broader implementation across the nation. Development will focus on expanding services, such as tracheostomy changes in the homes, and on creating sustainable models for similar initiatives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard Medical School, Massachusetts General Hospital, Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Boston, Massachusetts, USA, harvard.edu.
- Compassionate Care ALS, Falmouth, Massachusetts, USA.
- Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA, spauldingrehab.org.
ORCID-Profile: Erica Scirocco, Jennifer Scalia, Benedetta Ugolini, Gabriella Casagrande, Doreen Ho, Jennifer L Hagar, Kristen Kingsley, Merit E Cudkowicz, Sabrina Paganoni, James D Berry
Zitieren
APA
Scirocco, E., Scalia, J., Ugolini, B., Casagrande, G., Ho, D., Hagar, J. L., Kingsley, K., Hoffman, R., Cooley, C., Cudkowicz, M. E., Paganoni, S., & Berry, J. D. (2026). The Amyotrophic Lateral Sclerosis House Call Program: A Single‐Center Experience in the United States. Neurology Research International, 2026(1). https://doi.org/10.1155/nri/6629960
Vancouver
Scirocco E, Scalia J, Ugolini B, Casagrande G, Ho D, Hagar JL, et al. The Amyotrophic Lateral Sclerosis House Call Program: A Single‐Center Experience in the United States. Neurology Research International. 2026;2026(1). doi:10.1155/nri/6629960
BibTeX
@article{Scirocco2026,
author = {Scirocco, Erica and Scalia, Jennifer and Ugolini, Benedetta and Casagrande, Gabriella and Ho, Doreen and Hagar, Jennifer L and Kingsley, Kristen and Hoffman, Ron and Cooley, Christopher and Cudkowicz, Merit E and Paganoni, Sabrina and Berry, James D},
title = {The Amyotrophic Lateral Sclerosis House Call Program: A Single‐Center Experience in the United States},
journal = {Neurology Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/nri/6629960}
}
EUVIMED